| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.046 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.011 | 0.8 |